Can antibodies predict heart damage after viral myocarditis?
Part of Heart & circulation, Infections clinical trials.
This study looks at whether certain antibodies in your blood can predict if viral myocarditis will lead to a weakened heart muscle (dilated cardiomyopathy). It may help doctors understand your risk and plan better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with viral myocarditis (inflammation of the heart caused by a virus)
- Your symptoms should have started within the last 30 days
- You must be between 18 and 75 years old
- You cannot have a serious active infection that is not getting better
- You cannot have an autoimmune disease like lupus or a weak immune system
- You must understand the study and agree to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain antibodies (proteins in your blood) can help predict how dilated cardiomyopathy will progress. By testing your blood, researchers hope to learn more about your condition and find better ways to manage it.
This study uses heart MRI scans to predict who might develop dangerous heart rhythms after recovering from myocarditis. It aims to find better ways to monitor patients and prevent emergencies.
This study looks back at people who were hospitalized for myocarditis (inflammation of the heart muscle) to see if a special measurement of blood flow in the tiny heart vessels can predict how well they do over the next year. The findings might help doctors better understand and treat this condition.
This study follows people who have been hospitalized for a sudden inflammation of the heart muscle (myocarditis) to understand their risk of developing irregular heartbeats (arrhythmias). It aims to identify who might need closer monitoring or extra treatment to prevent complications.
This study tests whether a special heart panel can help doctors better manage and treat children with myocarditis (heart inflammation) that is causing irregular heartbeats or heart weakness. It aims to improve care for young patients with more serious forms of the condition.
This study looks at certain markers in your blood to better understand the risk level of myocarditis (inflammation of the heart muscle). It may help doctors know how to best monitor and treat your condition.
Hear when a new Viral Myocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.